Munck Wilson Mandala provides strategic biotech legal counsel by implementing our team’s real-world experience in the industry. Attorneys are qualified in a variety of fields such as medical devices, pharmaceuticals, imaging systems, microbiology, chemistry, physics, and genetic engineering. We provide in-depth knowledge pertaining to patents, trade secrets, financing, and regulatory protocols.

With extensive experience as advisors to innovators, entrepreneurs, and venture capitalists, our team is equipped to handle a wide spectrum of biotech matters. We are incredibly proud to assist organizations pioneering cutting edge biotech and life-changing medical advancements with the legal expertise necessary to succeed.

With extensive experience as advisors to innovators, entrepreneurs, and venture capitalists, our team is equipped to handle a wide spectrum of biotech matters. We are incredibly proud to assist organizations pioneering cutting edge biotech and life-changing medical advancements with the legal expertise necessary to succeed.

Munck Wilson Mandala offers legal services that cater to each companies’ unique goals by providing general counsel as well as niche services to achieve organizational milestones such as formation, funding, regulatory assistance, licensing, IP portfolio management, and more.

Our biotech team brings you considerable IP strength with more than 30 registered patent attorneys who handle extensive patent portfolios for clients in medicine, health care, biochemistry, digital health, therapeutics, and diagnostics. We are well known for our thorough knowledge of your industry and relied upon to help dozens of clients protect their IP assets.

We have a transactional team well-versed in representing entrepreneurs and investors in regulatory and financial matters necessary to succeed in biotech, and we have our award-winning litigation team, with a proven track record of successfully representing clients in disputes related to biotech and life science matters.

Press Releases

Munck Wilson Mandala Names Merritt D. Westcott Chair of Firm’s Expanding Life Sciences Practice

Westcott has built her reputation as a go-to trial lawyer in high-stakes biotech and pharmaceutical patent disputes, representing clients across genetically engineered crops and food products, monoclonal antibodies, blood cell controls, MedTech devices, and both traditional and biosimilar pharmaceuticals under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act. “Merritt combines world-class legal

| 3 minute read

Press Releases

Munck Wilson Mandala welcomes life sciences partner Denise Mayfield

Mayfield focuses her practice on the drafting and prosecution of patents primarily in life science, chemistry, biotechnology, medical devices, and bio-electrical (sensor) technologies. She also creates and manages client patent portfolios, performs various due diligence services (pre- and post-litigation), prepares/negotiates technology licensing and other corporate agreements (collaborative research agreements, joint venture agreements, joint research and

| 2 minute read

Press Releases

Munck Wilson Mandala adds Partner and Scientific Advisor to Life Sciences Practice

Munck Wilson Mandala has added additional talent to its life sciences practice, offering a comprehensive legal solution for businesses at the forefront of biotechnology, pharmaceuticals, diagnostics and medical devices. The MWM life sciences group features a multidisciplinary team of attorneys and patent professionals with advanced degrees in genetics, molecular biology, chemistry, mechanical and electrical engineering,

| 2 minute read

Press Releases

Munck Wilson Mandala Welcomes IP Litigation Partner Merritt Westcott

Recognized in the IAM Patent 1000 as a top-tier litigator, Westcott has built a reputation for her deep understanding of complex scientific and technical issues and her ability to translate these complexities into actionable, strategic advice for clients. Her focus on aligning legal strategies with business objectives has made her a trusted advisor to innovators

| 2 minute read